skip to Main Content

Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice

Long-Term Administration Of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline In Mice

Authors
Kathryn F. Mills, Shohei Yoshida,
Liana R. Stein, …, Koji Uchida,
Jun Yoshino, Shin-ichiro Imai

Correspondence
jyoshino@wustl.edu (J.Y.),
imaishin@wustl.edu (S.I.)


Mills et al. conducted a 12-month-long administration of nicotinamide mononucleotide (NMN), a key natural NAD+ intermediate, to normal wild-type mice, demonstrating that NMN effectively mitigates age-associated physiological decline in mice without any obvious toxicity. These results highlight the significant potential of NMN as an effective anti-aging intervention in humans.

About Us

At EZZ, we focus on improving general wellbeing and promoting healthy lifestyle, we truely love what we do and that's why we will always bring the best quality products to our customers.

Come Say Hi

info@ezz.co.nz

www.ezz.co.nz

EZZ Australia & New Zealand © All Rights Reserved